23 January 2024
Morressier, the Berlin-based startup has announced it has attracted $16.5m in investment in a Series B round led by Molten Ventures and with the participation of existing investors including Redalpine, Owl Ventures, and Cherry Ventures. This growth investment follows the company’s Series A round communicated in May 2021, and will be topped up with further funding for acquisition opportunities.
Morressier counts some of the industry's leading players in the scientific ecosystem as customers, including: IOP Publishing, AAAS, ASCE, APS, and Mayo Clinic. The company will use its Series B growth capital for continued product innovation, scaling its go-to-market activities, including the institutional and corporate market, and to expand partnerships with leading research integrity vendors.
Sami Benchekroun, Morressier co-founder and CEO: “Attracting such strong support from investors in this climate is the ultimate validation that Morressier is doing critical work. Science is experiencing an integrity crisis and this investment will help us to double down on our efforts to support academic societies, institutions and publishers in this fight.”
Christoph Hornung, partner at Molten Ventures said, "There is a massive need for a new infrastructure in the science world, and we are convinced that Morressier with its highly experienced team will be shaping the new structure of this industry in the following years."